Please enable JavaScript to continue using this application.

Compare $ARDX vs $IMMX | Chartloom

Compare

$ARDX vs $IMMX

Ardelyx Inc · Immix Biopharma Inc

ARDX

Ardelyx Inc

IMMX

Immix Biopharma Inc

Compare $ARDX vs $IMMX

Comparing Ardelyx Inc and Immix Biopharma Inc

ARDXArdelyx Inc

IMMXImmix Biopharma Inc

ARDXArdelyx Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

688.58x

Forward P/S (NTM)

1.51x

Rev growth (TTM)

16.8%

YTD performance

-46.7%

52W performance

-35.2%

FCF yield

-2.2%

IMMXImmix Biopharma Inc

Market cap

$660M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

74.2%

52W performance

272.4%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARDX

IMMX

Detailed metrics comparison

ARDX

Ardelyx Inc

IMMX

Immix Biopharma Inc

Market Cap

ARDX$810M

IMMX$660M

Enterprise Value

ARDX$965M

IMMX$435M

Price

ARDX$3.28

IMMX$9.46

P/E Ratio

ARDXN/A

IMMXN/A

P/S Ratio

ARDX1.80x

IMMX0.00x

EV/Sales

ARDX2.14x

IMMX0.00x

EV/EBITDA

ARDX454.80x

IMMX0.00x

P/B Ratio

ARDX5.59x

IMMX3.03x

P/FCF Ratio

ARDXN/A

IMMXN/A

EV/FCF

ARDX-53.85x

IMMX-11.12x

PEG Ratio

ARDXN/A

IMMXN/A

Forward P/E (NTM)

ARDX688.58x

IMMXN/A

Forward P/S (NTM)

ARDX1.51x

IMMXN/A

Revenue (TTM)

ARDX$451M

IMMX$0

Revenue Growth (YoY)

ARDX16.8%

IMMXN/A

Forward Rev Growth

ARDX27.5%

IMMX452.1%

Gross Margin (TTM)

ARDX94.4%

IMMX0.0%

Operating Margin (TTM)

ARDX0.0%

IMMX0.0%

EBITDA Margin (TTM)

ARDX-7.1%

IMMX0.0%

Net Margin (TTM)

ARDX-12.4%

IMMX0.0%

FCF Margin (TTM)

ARDX-4.0%

IMMXN/A

Net Income (TTM)

ARDX$-56M

IMMX$-40M

FCF (TTM)

ARDX$-18M

IMMX$-39M

EPS (TTM)

ARDX-$0.22

IMMX-$0.63

ROE (TTM)

ARDX-3600.0%

IMMX-3844.0%

ROA (TTM)

ARDX-1077.0%

IMMX-3472.0%

ROIC (TTM)

ARDX-1506.0%

IMMX-3844.0%

Cash

ARDX$97M

IMMX$225M

Debt

ARDX$252M

IMMX$0

Net Cash/Debt

ARDX$-155M

IMMX$225M

Current Ratio (TTM)

ARDX3.34x

IMMX25.13x

Quick Ratio (TTM)

ARDX2.89x

IMMX24.98x

Debt/Equity (TTM)

ARDX1.69x

IMMX0.00x

Debt/Assets (TTM)

ARDX0.0%

IMMX0.0%

Interest Coverage (TTM)

ARDXN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

IMMX0.00x

Beta

ARDX0.72

IMMX0.22

52W Performance

ARDX-35.2%

IMMX272.4%

YTD Performance

ARDX-46.7%

IMMX74.2%

% from 52W High

ARDX-61.0%

IMMX-37.4%

% from 52W Low

ARDX3.1%

IMMX309.5%

Asset Turnover (TTM)

ARDX0.87x

IMMX0.00x

FCF Yield (TTM)

ARDX-2.2%

IMMX-5.9%

Earnings Yield (TTM)

ARDX-6.9%

IMMX-6.0%

Dividend Yield (TTM)

ARDXN/A

IMMXN/A

Rule of 40

ARDX12.8

IMMX0.0

EV/GP/RG

ARDX0.10

IMMXN/A

Ticker research

View ARDX research View IMMX research

Metric	ARDX Ardelyx Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$810M	$660M
Enterprise Value	$965M	$435M
Price	$3.28	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	0.00x
EV/Sales	2.14x	0.00x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$0
Revenue Growth (YoY)	16.8%	N/A
Forward Rev Growth	27.5%	452.1%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	0.0%
Net Margin (TTM)	-12.4%	0.0%
FCF Margin (TTM)	-4.0%	N/A
Net Income (TTM)	$-56M	$-40M
FCF (TTM)	$-18M	$-39M
EPS (TTM)	-$0.22	-$0.63
ROE (TTM)	-3600.0%	-3844.0%
ROA (TTM)	-1077.0%	-3472.0%
ROIC (TTM)	-1506.0%	-3844.0%
Financial Health
Cash	$97M	$225M
Debt	$252M	$0
Net Cash/Debt	$-155M	$225M
Current Ratio (TTM)	3.34x	25.13x
Quick Ratio (TTM)	2.89x	24.98x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	0.22
52W Performance	-35.2%	272.4%
YTD Performance	-46.7%	74.2%
% from 52W High	-61.0%	-37.4%
% from 52W Low	3.1%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-5.9%
Earnings Yield (TTM)	-6.9%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View IMMX research

Valuation

P/S Ratio

IMMX

0.00x

ARDX

1.80x

EV/FCF

ARDX

-53.85x

IMMX

-11.12x

Growth & revenue

Revenue Growth TTM

ARDX

16.8%

Forward Revenue Growth

IMMX

452.1%

ARDX

27.5%

Profitability & performance

Gross Margin

ARDX

94.4%

IMMX

0.0%

ROE

ARDX

-3600.0%

IMMX

-3844.0%

FCF Yield %

ARDX

-2.2%

IMMX

-5.9%

52-Week Performance

IMMX

272.4%

ARDX

-35.2%

Detailed metrics comparison

ARDX

Ardelyx Inc

IMMX

Immix Biopharma Inc

Market Cap

ARDX$810M

IMMX$660M

Enterprise Value

ARDX$965M

IMMX$435M

Price

ARDX$3.28

IMMX$9.46

P/E Ratio

ARDXN/A

IMMXN/A

P/S Ratio

ARDX1.80x

IMMX0.00x

EV/Sales

ARDX2.14x

IMMX0.00x

EV/EBITDA

ARDX454.80x

IMMX0.00x

P/B Ratio

ARDX5.59x

IMMX3.03x

P/FCF Ratio

ARDXN/A

IMMXN/A

EV/FCF

ARDX-53.85x

IMMX-11.12x

PEG Ratio

ARDXN/A

IMMXN/A

Forward P/E (NTM)

ARDX688.58x

IMMXN/A

Forward P/S (NTM)

ARDX1.51x

IMMXN/A

Revenue (TTM)

ARDX$451M

IMMX$0

Revenue Growth (YoY)

ARDX16.8%

IMMXN/A

Forward Rev Growth

ARDX27.5%

IMMX452.1%

Gross Margin (TTM)

ARDX94.4%

IMMX0.0%

Operating Margin (TTM)

ARDX0.0%

IMMX0.0%

EBITDA Margin (TTM)

ARDX-7.1%

IMMX0.0%

Net Margin (TTM)

ARDX-12.4%

IMMX0.0%

FCF Margin (TTM)

ARDX-4.0%

IMMXN/A

Net Income (TTM)

ARDX$-56M

IMMX$-40M

FCF (TTM)

ARDX$-18M

IMMX$-39M

EPS (TTM)

ARDX-$0.22

IMMX-$0.63

ROE (TTM)

ARDX-3600.0%

IMMX-3844.0%

ROA (TTM)

ARDX-1077.0%

IMMX-3472.0%

ROIC (TTM)

ARDX-1506.0%

IMMX-3844.0%

Cash

ARDX$97M

IMMX$225M

Debt

ARDX$252M

IMMX$0

Net Cash/Debt

ARDX$-155M

IMMX$225M

Current Ratio (TTM)

ARDX3.34x

IMMX25.13x

Quick Ratio (TTM)

ARDX2.89x

IMMX24.98x

Debt/Equity (TTM)

ARDX1.69x

IMMX0.00x

Debt/Assets (TTM)

ARDX0.0%

IMMX0.0%

Interest Coverage (TTM)

ARDXN/A

IMMXN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

IMMX0.00x

Beta

ARDX0.72

IMMX0.22

52W Performance

ARDX-35.2%

IMMX272.4%

YTD Performance

ARDX-46.7%

IMMX74.2%

% from 52W High

ARDX-61.0%

IMMX-37.4%

% from 52W Low

ARDX3.1%

IMMX309.5%

Asset Turnover (TTM)

ARDX0.87x

IMMX0.00x

FCF Yield (TTM)

ARDX-2.2%

IMMX-5.9%

Earnings Yield (TTM)

ARDX-6.9%

IMMX-6.0%

Dividend Yield (TTM)

ARDXN/A

IMMXN/A

Rule of 40

ARDX12.8

IMMX0.0

EV/GP/RG

ARDX0.10

IMMXN/A

Ticker research

View ARDX research View IMMX research

Metric	ARDX Ardelyx Inc	IMMX Immix Biopharma Inc
Market & Valuation
Market Cap	$810M	$660M
Enterprise Value	$965M	$435M
Price	$3.28	$9.46
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	0.00x
EV/Sales	2.14x	0.00x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	3.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-11.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$0
Revenue Growth (YoY)	16.8%	N/A
Forward Rev Growth	27.5%	452.1%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	0.0%
Net Margin (TTM)	-12.4%	0.0%
FCF Margin (TTM)	-4.0%	N/A
Net Income (TTM)	$-56M	$-40M
FCF (TTM)	$-18M	$-39M
EPS (TTM)	-$0.22	-$0.63
ROE (TTM)	-3600.0%	-3844.0%
ROA (TTM)	-1077.0%	-3472.0%
ROIC (TTM)	-1506.0%	-3844.0%
Financial Health
Cash	$97M	$225M
Debt	$252M	$0
Net Cash/Debt	$-155M	$225M
Current Ratio (TTM)	3.34x	25.13x
Quick Ratio (TTM)	2.89x	24.98x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	0.22
52W Performance	-35.2%	272.4%
YTD Performance	-46.7%	74.2%
% from 52W High	-61.0%	-37.4%
% from 52W Low	3.1%	309.5%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-5.9%
Earnings Yield (TTM)	-6.9%	-6.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	0.0
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View IMMX research